Skip to main content
Year archive

Galapagos NV — 2018 filings

All 205 regulatory filings released by Galapagos NV (GLPG) in 2018, sourced directly from the official regulator.

205 Filings
2018 Period
2018 filings (205)
Filing Released Lang
6-K Filing
Foreign Filer Report
2018-12-26 English
Galapagos to Present at 37th Annual J.P. Morgan Healthcare Conference
Report Publication Announcement
2018-12-24 English
Galapagos to Present at 37th Annual J.P. Morgan Healthcare Conference
Investor Presentation
2018-12-24 English
Galapagos reports initiation of ISABELA Phase 3 program with GLPG1690 in patients with Idiopathic Pulmonary Fibrosis (IPF)
Regulatory Filings
2018-12-18 English
Galapagos reports initiation of ISABELA Phase 3 program with GLPG1690 in patients with Idiopathic Pulmonary Fibrosis (IPF)
Regulatory Filings
2018-12-18 English
6-K Filing
Foreign Filer Report
2018-12-18 English
Galapagos receives Fast Track designation from FDA for GLPG1972/S201086 in osteoarthritis
Earnings Release Q4 2018
2018-11-28 English
Galapagos receives Fast Track designation from FDA for GLPG1972/S201086 in osteoarthritis
Regulatory Filings
2018-11-28 English
6-K Filing
Foreign Filer Report
2018-11-28 English
Transparency notification
Major Shareholding Notification
2018-11-27 English
Transparency notification
Major Shareholding Notification
2018-11-27 English
6-K Filing
Foreign Filer Report
2018-11-27 English
VANHERK26November2018_def.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-11-26 English
VANHERK26November2018_NL_def.pdf
Major Shareholding Notification
2018-11-26 Dutch
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2018-11-26 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2018-11-26 English
6-K Filing
Foreign Filer Report
2018-11-26 English
Share Capital Increase - 23-Nov-2018 - EN.pdf
Share Issue/Capital Change
2018-11-23 English
Share Capital Increase - 23-Nov-2018 - NL.pdf
Share Issue/Capital Change
2018-11-23 Dutch
SC 13G/A Filing
Major Shareholding Notification
2018-11-23 English
Galapagos reports initiation of PINTA Phase 2 trial with GLPG1205 in patients with Idiopathic Pulmonary Fibrosis (IPF)
Regulatory Filings
2018-11-01 English
Galapagos reports initiation of PINTA Phase 2 trial with GLPG1205 in patients with Idiopathic Pulmonary Fibrosis (IPF)
Regulatory Filings
2018-11-01 English
6-K Filing
Foreign Filer Report
2018-11-01 English
6-K Filing
Foreign Filer Report
2018-10-26 English
Galapagos and AbbVie restructure CF collaboration
Regulatory Filings
2018-10-25 English
Galapagos and AbbVie restructure CF collaboration
Capital/Financing Update
2018-10-25 English
Topline interim results of FALCON trial Part 1 in CF
Earnings Release FY 2018
2018-10-25 English
Topline interim results of FALCON trial Part 1 in CF
Earnings Release Q4 2018
2018-10-25 English
Hallmark third quarter 2018 and Annual R&D Update at Galapagos
Earnings Release 9M 2018
2018-10-25 English
Hallmark third quarter 2018 and Annual R&D Update at Galapagos
Earnings Release 9M 2018
2018-10-25 English
6-K Filing
Foreign Filer Report
2018-10-25 English
6-K Filing
Foreign Filer Report
2018-10-25 English
Hallmark third quarter 2018 and Annual R&D Update at Galapagos.pdf
Earnings Release 9M 2018
2018-10-24 English
Uitstekend derde kwartaal 2018 & jaarlijkse R&D Update bij Galapagos.pdf
Earnings Release 9M 2018
2018-10-24 Dutch
Q3 report 2018.pdf
Interim / Quarterly Report 9M 2018
2018-10-24 English
Q3 verslag 2018.pdf
Interim / Quarterly Report 9M 2018
2018-10-24 Dutch
Hallmark third quarter 2018 and Annual R&D Update at Galapagos
Earnings Release 9M 2018
2018-10-24 English
Uitstekend derde kwartaal 2018 & jaarlijkse R&D Update bij Galapagos
Earnings Release 9M 2018
2018-10-24 Dutch
Galapagos and AbbVie restructure CF collaboration
Capital/Financing Update
2018-10-24 English
Galapagos en AbbVie herstructureren samenwerking in CF
Capital/Financing Update
2018-10-24 Dutch
Topline interim results of FALCON trial Part 1 in CF
Earnings Release FY 2018
2018-10-24 English
Tussentijdse resultaten van het eerste deel van de FALCON studie in CF
Earnings Release Q4 2018
2018-10-24 Dutch
POSITIVE TRIAL RESULTS WITH FILGOTINIB IN PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS BOTH PUBLISHED IN THE LANCET
Earnings Release Q4 2018
2018-10-23 English
POSITIVE TRIAL RESULTS WITH FILGOTINIB IN PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS BOTH PUBLISHED IN THE LANCET
Earnings Release Q2 2018
2018-10-23 English
6-K Filing
Foreign Filer Report
2018-10-23 English
PHASE 3 DATA ON FILGOTINIB IN BIOLOGIC-EXPERIENCED RHEUMATOID ARTHRITIS TO BE PRESENTED AT 2018 ACR/ARHP ANNUAL MEETING
Earnings Release Q3 2018
2018-10-22 English
PHASE 3 DATA ON FILGOTINIB IN BIOLOGIC-EXPERIENCED RHEUMATOID ARTHRITIS TO BE PRESENTED AT 2018 ACR/ARHP ANNUAL MEETING
Earnings Release Q3 2018
2018-10-22 English
6-K Filing
Foreign Filer Report
2018-10-22 English
424B3 Filing
Prospectus
2018-10-15 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2018-10-04 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2018-10-04 English
6-K Filing
Foreign Filer Report
2018-10-04 English
Share Capital Increase - 3 Oct 2018_EN.pdf
Share Issue/Capital Change
2018-10-03 English
Share Capital Increase - 3 Oct 2018_NL.pdf
Share Issue/Capital Change
2018-10-03 Dutch
Galapagos reports initiation of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in osteoarthritis patients
Regulatory Filings
2018-09-24 English
Galapagos reports initiation of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in osteoarthritis patients
Regulatory Filings
2018-09-24 English
6-K Filing
Foreign Filer Report
2018-09-24 English
Galapagos announces closing of public offering of American Depositary Shares for gross proceeds of €296.2 million
Share Issue/Capital Change
2018-09-18 English
Galapagos announces closing of public offering of American Depositary Shares for gross proceeds of €296.2 million
Share Issue/Capital Change
2018-09-18 English
Galapagos issues new shares as result of public offering
Share Issue/Capital Change
2018-09-18 English
Galapagos issues new shares as result of public offering
Share Issue/Capital Change
2018-09-18 English
6-K Filing
Foreign Filer Report
2018-09-18 English
6-K Filing
Foreign Filer Report
2018-09-18 English
Galapagos announces closing of public offering of American Depositary Shares for gross proceeds of €296.2 million
Share Issue/Capital Change
2018-09-17 English
Galapagos kondigt afsluiting openbare aanbieding van American Depositary Shares aan met een bruto-opbrengst van €296,2 miljoen
Share Issue/Capital Change
2018-09-17 Dutch
Technical denominator Press Release_EN.pdf
Share Issue/Capital Change
2018-09-17 English
Technical denominator Press Release_NL.pdf
Share Issue/Capital Change
2018-09-17 Dutch
Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106
Investor Presentation
2018-09-14 English
Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106
Regulatory Filings
2018-09-14 English
6-K Filing
Foreign Filer Report
2018-09-14 English
6-K Filing
Foreign Filer Report
2018-09-14 English
424B5 Filing
Prospectus
2018-09-14 English
MorphoSys and Galapagos announce U.S. Antitrust Clearance for global license agreement for MOR106 with pharma partner
M&A Activity
2018-09-13 English
MorphoSys and Galapagos announce U.S. Antitrust Clearance for global license agreement for MOR106 with pharma partner
Regulatory Filings
2018-09-13 English
Galapagos announces launch of proposed public offering
Capital/Financing Update
2018-09-13 English
Galapagos announces launch of proposed public offering
Capital/Financing Update
2018-09-13 English
Galapagos raises $300 million gross proceeds in a U.S. public offering
Share Issue/Capital Change
2018-09-13 English
Galapagos raises $300 million gross proceeds in a U.S. public offering
Share Issue/Capital Change
2018-09-13 English
Galapagos raises $300 million gross proceeds in a U.S. public offering
Share Issue/Capital Change
2018-09-13 English
Galapagos haalt $300 miljoen op met een openbare aanbieding van aandelen in de Verenigde Staten
Share Issue/Capital Change
2018-09-13 Dutch
6-K Filing
Foreign Filer Report
2018-09-13 English
6-K Filing
Foreign Filer Report
2018-09-13 English
424B5 Filing
Prospectus
2018-09-13 English
6-K Filing
Foreign Filer Report
2018-09-13 English
Galapagos kondigt start voorgenomen openbare aanbieding aan
Capital/Financing Update
2018-09-12 Dutch
LM-GLPG-UitgifteOphVoork-art596-12Sept2018-EN-SignedbyDeloitte.pdf
Share Issue/Capital Change
2018-09-12 English
LM-GLPG-UitgifteOphVoork-art596-12Sept2018-NL-SignedbyDeloitte.pdf
Share Issue/Capital Change
2018-09-12 Dutch
Madison_Board Report 596_ENG.pdf
Capital/Financing Update
2018-09-12 English
Madison_Board Report 596_NED.pdf
Capital/Financing Update
2018-09-12 Dutch
GILEAD AND GALAPAGOS ANNOUNCE FILGOTINIB MEETS PRIMARY AND ALL KEY SECONDARY ENDPOINTS IN FIRST PHASE 3 STUDY IN RHEUMATOID ARTHRITIS
Regulatory Filings
2018-09-12 English
GILEAD AND GALAPAGOS ANNOUNCE FILGOTINIB MEETS PRIMARY AND ALL KEY SECONDARY ENDPOINTS IN FIRST PHASE 3 STUDY IN RHEUMATOID ARTHRITIS
Regulatory Filings
2018-09-12 English
6-K Filing
Foreign Filer Report
2018-09-11 English
Gilead and Galapagos announce filgotinib meets primary and all key secondary endpoints in first Phase 3 studie in RA
Regulatory Filings
2018-09-11 English
GILEAD EN GALAPAGOS KONDIGEN AAN DAT FILGOTINIB ALLE BELANGRIJKE ONDERZOEKSDOELEN HEEFT GEHAALD IN EERSTE REUMA FASE 3 STUDIE
Regulatory Filings
2018-09-11 Dutch
GILEAD AND GALAPAGOS ANNOUNCE TORTUGA PHASE 2 STUDY OF FILGOTINIB IN ANKYLOSING SPONDYLITIS ACHIEVES PRIMARY ENDPOINT
Earnings Release Q3 2018
2018-09-06 English
GILEAD AND GALAPAGOS ANNOUNCE TORTUGA PHASE 2 STUDY OF FILGOTINIB IN ANKYLOSING SPONDYLITIS ACHIEVES PRIMARY ENDPOINT
Earnings Release Q3 2018
2018-09-06 English
6-K Filing
Foreign Filer Report
2018-09-06 English
GILEAD AND GALAPAGOS ANNOUNCE TORTUGA PHASE 2 STUDY OF FILGOTINIB IN ANKYLOSING SPONDYLITIS ACHIEVES PRIMARY ENDPOINT
Earnings Release Q3 2018
2018-09-06 English
GILEAD EN GALAPAGOS KONDIGEN HET BEREIKEN VAN HET PRIMAIRE EINDPUNT AAN IN DE TORTUGA FASE 2 STUDIE MET FILGOTINIB IN DE ZIEKTE VAN BECHTEREW
Earnings Release Q3 2018
2018-09-06 Dutch
Productive first half-year at Galapagos
Earnings Release H1 2018
2018-08-03 English
Productive first half-year at Galapagos
Earnings Release H1 2018
2018-08-03 English
6-K Filing
Foreign Filer Report
2018-08-02 English
5b63646986ee7-en.pdf
Interim / Quarterly Report H1 2018
2018-08-02 English
5b63646986ee7-nl.pdf
Interim / Quarterly Report H1 2018
2018-08-02 Dutch
PR H1 2018_ENG_final.pdf
Earnings Release H1 2018
2018-08-02 English
PR H1 2018_NL_final.pdf
Earnings Release H1 2018
2018-08-02 Dutch
MorphoSys and Galapagos Sign Global License Agreement for MOR106 with Top Pharma Partner
Capital/Financing Update
2018-07-19 English
MorphoSys and Galapagos Sign Global License Agreement for MOR106 with Top Pharma Partner
Regulatory Filings
2018-07-19 English
6-K Filing
Foreign Filer Report
2018-07-19 English
MorphoSys en Galapagos tekenen wereldwijde licentieovereenkomst voor MOR106 met top farma partner
Capital/Financing Update
2018-07-19 Dutch
Galapagos announces design for PINTA Phase 2 trial with GLPG1205 in IPF
Regulatory Filings
2018-07-09 English
6-K Filing
Foreign Filer Report
2018-07-09 English
Topline results of PELICAN trial and update on triple combo development plans
Regulatory Filings
2018-06-29 English
Topline results of PELICAN trial and update on triple combo development plans
Earnings Release Q2 2018
2018-06-29 English
6-K Filing
Foreign Filer Report
2018-06-29 English
Topline results of PELICAN trial and update on triple combo development plans
Regulatory Filings
2018-06-28 English
Resultaten van PELICAN trial en update over plannen voor drievoudige combinatietherapie in CF
Earnings Release Q2 2018
2018-06-28 Dutch
Servier and Galapagos announce start of global ROCCELLA Phase 2 clinical trial with S201086/GLPG1972 in osteoarthritis patients
Regulatory Filings
2018-06-27 English
Servier and Galapagos announce start of global ROCCELLA Phase 2 clinical trial with S201086/GLPG1972 in osteoarthritis patients
Regulatory Filings
2018-06-27 English
6-K Filing
Foreign Filer Report
2018-06-27 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2018-06-21 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2018-06-21 English
6-K Filing
Foreign Filer Report
2018-06-21 English
Share Capital Increase - 20 June 2018_EN.pdf
Share Issue/Capital Change
2018-06-20 English
Share Capital Increase - 20 June 2018_NL.pdf
Share Issue/Capital Change
2018-06-20 Dutch
Transparency notification
Major Shareholding Notification
2018-06-15 English
Transparency notification
Major Shareholding Notification
2018-06-15 English
6-K Filing
Foreign Filer Report
2018-06-15 English
SC 13G/A Filing
Major Shareholding Notification
2018-06-12 English
VANHERK14June2018_def.pdf
Major Shareholding Notification
2018-06-12 English
VANHERK14June2018_NL_def.pdf
Declaration of Voting Results & Voting Rights Announcements
2018-06-12 Dutch
6-K Filing
Foreign Filer Report
2018-06-05 English
GILEAD AND GALAPAGOS ANNOUNCE RESULTS WITH FILGOTINIB IN THE PHASE 2 EQUATOR STUDY IN PSORIATIC ARTHRITIS AND PROGRESSION INTO PHASE 3 FOR THE SELECTION STUDY IN ULCERATIVE COLITIS
Earnings Release Q1 2018
2018-05-31 English
GILEAD AND GALAPAGOS ANNOUNCE RESULTS WITH FILGOTINIB IN THE PHASE 2 EQUATOR STUDY IN PSORIATIC ARTHRITIS AND PROGRESSION INTO PHASE 3 FOR THE SELECTION STUDY IN ULCERATIVE COLITIS
Regulatory Filings
2018-05-31 English
GILEAD AND GALAPAGOS ANNOUNCE RESULTS WITH FILGOTINIB IN THE PHASE 2 EQUATOR STUDY IN PSORIATIC ARTHRITIS AND PROGRESSION INTO PHASE 3 FOR THE SELECTION STUDY IN ULCERATIVE COLITIS
Regulatory Filings
2018-05-30 English
GILEAD EN GALAPAGOS KONDIGEN DE RESULTATEN MET FILGOTINIB AAN IN DE FASE 2 EQUATOR STUDIE IN ARTRITIS PSORIATICA EN DE VOORTGANG NAAR FASE 3 VOOR DE SELECTIE STUDIE IN COLITIS ULCEROSA
Earnings Release Q1 2018
2018-05-30 Dutch
S-8 Filing
Registration Form
2018-05-29 English
6-K Filing
Foreign Filer Report
2018-05-22 English
GLPG1690 results in IPF published in The Lancet Respiratory Medicine and presented at ATS
Earnings Release Q2 2018
2018-05-21 English
GLPG1690 results in IPF published in The Lancet Respiratory Medicine and presented at ATS
Regulatory Filings
2018-05-21 English
Galapagos and MorphoSys announce initiation of the IGUANA Phase 2 clinical trial with MOR106 in atopic dermatitis patients
Regulatory Filings
2018-05-02 English
Galapagos and MorphoSys announce initiation of the IGUANA Phase 2 clinical trial with MOR106 in atopic dermatitis patients
Regulatory Filings
2018-05-02 English
6-K Filing
Foreign Filer Report
2018-05-02 English
6-K Filing
Foreign Filer Report
2018-05-01 English
Galapagos presents strong disease-modifying effects in preclinical model of osteoarthritis with GLPG1972 at OARSI 2018
Regulatory Filings
2018-04-27 English
Galapagos presents strong disease-modifying effects in preclinical model of osteoarthritis with GLPG1972 at OARSI 2018
Regulatory Filings
2018-04-27 English
6-K Filing
Foreign Filer Report
2018-04-27 English
Galapagos reports first quarter 2018 results
Earnings Release Q1 2018
2018-04-26 English
Galapagos reports first quarter 2018 results
Earnings Release Q1 2018
2018-04-26 English
Hallmark third quarter 2018 and Annual R&D Update at Galapagos.pdf
Earnings Release 9M 2018
2018-04-25 English
Uitstekend derde kwartaal 2018 & jaarlijkse R&D Update bij Galapagos.pdf
Earnings Release 9M 2018
2018-04-25 Dutch
Q1 report 2018.pdf
Interim / Quarterly Report Q1 2018
2018-04-25 English
Q1 verslag 2018.pdf
Interim / Quarterly Report Q1 2018
2018-04-25 Dutch
Minutes of the ordinary annual shareholders' meeting 2018.pdf
AGM Information
2018-04-25 English
Notulen van de gewone algemene vergadering 2018.pdf
AGM Information
2018-04-25 Dutch
6-K Filing
Foreign Filer Report
2018-04-25 English
Galapagos reports initiation of FALCON clinical trial in cystic fibrosis
Regulatory Filings
2018-04-24 English
Galapagos reports initiation of FALCON clinical trial in cystic fibrosis
Regulatory Filings
2018-04-24 English
6-K Filing
Foreign Filer Report
2018-04-24 English
Galapagos creates new warrant plan
Remuneration Information
2018-04-20 English
Galapagos creates new warrant plan
Remuneration Information
2018-04-20 English
Warrant-GLPG-UitgifteOphefVoorkeurrecht-Art 596.598-EN.pdf
Share Issue/Capital Change
2018-04-19 English
Warrant Plan 2018_BoD Report_596-598_D.pdf
Board/Management Information
2018-04-19 Dutch
Warrant Plan 2018_BoD Report_596-598_E.pdf
Share Issue/Capital Change
2018-04-19 English
Warrant-GLPG-UitgifteOphefVoorkeurrecht-Art 596.598-NL.pdf
Capital/Financing Update
2018-04-19 Dutch
Warrant Plan 2018_BoD Report_583_E.pdf
Capital/Financing Update
2018-04-19 English
Warrant Plan 2018_BoD Report_583_D.pdf
Remuneration Information
2018-04-19 Dutch
6-K Filing
Foreign Filer Report
2018-04-16 English
Galapagos announces ISABELA Phase 3 program in IPF
Regulatory Filings
2018-04-13 English
Publication of the annual report and invitation to the annual shareholders' meeting
Report Publication Announcement
2018-03-26 English
Publication of the annual report and invitation to the annual shareholders' meeting
Report Publication Announcement
2018-03-26 English
1. Convening Notice - D.pdf
AGM Information
2018-03-23 Dutch
3. Attendance Notification Form.pdf
AGM Information
2018-03-23 Dutch
7. Number of shares and voting rights.pdf
Share Issue/Capital Change
2018-03-23 Dutch
2. Proxy Form.pdf
Proxy Solicitation & Information Statement
2018-03-23 Dutch
nxr_glpg_ar17_final_EN.pdf
Annual Report FY 2017
2018-03-23 English
6. Statutory auditor's report on the non-consolidated financial statements per 31 December 2017_D.pdf
Audit Report / Information FY 2017
2018-03-23 Dutch
6. Statutory auditor's report on the non-consolidated financial statements per 31 December 2017_E.pdf
Audit Report / Information FY 2017
2018-03-23 English
nxr_glpg_ar17_final_NL.pdf
Annual Report FY 2017
2018-03-23 Dutch
1. Convening Notice - E.pdf
AGM Information
2018-03-23 English
5. Non-consolidated financial statements per 31 December 2017.pdf
Annual Report FY 2017
2018-03-23 Dutch
Publication AR and AGM Convening Notice_EN.pdf
Report Publication Announcement
2018-03-23 English
Publication AR and AGM Convening Notice_NL.pdf
Report Publication Announcement
2018-03-23 Dutch
20-F Filing
Annual Report FY 2017
2018-03-23 English
6-K Filing
Foreign Filer Report
2018-03-23 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2018-03-21 English
Galapagos increases share capital through warrant exercises
Share Issue/Capital Change
2018-03-21 English
6-K Filing
Foreign Filer Report
2018-03-21 English
Share Capital Increase - 20 March 2018_EN.pdf
Share Issue/Capital Change
2018-03-20 English
Share Capital Increase - 20 March 2018_NL.pdf
Share Issue/Capital Change
2018-03-20 Dutch
Galapagos delivered in 2017
Earnings Release FY 2017
2018-02-23 English
Galapagos delivered in 2017
Earnings Release FY 2017
2018-02-23 English
FY2017_ENG.pdf
Earnings Release FY 2017
2018-02-22 English
FY2017_NL.pdf
Earnings Release FY 2017
2018-02-22 Dutch
6-K Filing
Foreign Filer Report
2018-02-20 English
Galapagos and MorphoSys present results from a Phase 1 study with MOR106 in atopic dermatitis as late-breaking abstract at the American Academy of Dermatology (AAD) meeting in San Diego
Earnings Release Q1 2018
2018-02-19 English
Galapagos and MorphoSys present results from a Phase 1 study with MOR106 in atopic dermatitis as late-breaking abstract at the American Academy of Dermatology (AAD) meeting in San Diego
Regulatory Filings
2018-02-19 English
SC 13G/A Filing
Major Shareholding Notification
2018-02-16 English
Positive topline results with GLPG1972 in osteoarthritis patients
Earnings Release Q1 2018
2018-01-08 English
Positive topline results with GLPG1972 in osteoarthritis patients
Earnings Release Q1 2018
2018-01-08 English
6-K Filing
Foreign Filer Report
2018-01-08 English
Update on progress in cystic fibrosis programs
Earnings Release Q1 2017
2018-01-03 English
Update on progress in cystic fibrosis programs
Regulatory Filings
2018-01-03 English
6-K Filing
Foreign Filer Report
2018-01-03 English
Update over de vooruitgang in cystic fibrosis programma
Earnings Release Q1 2017
2018-01-02 Dutch